115 related articles for article (PubMed ID: 10083982)
21. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
[TBL] [Abstract][Full Text] [Related]
22. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
23. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
24. Oral bioavailability and pharmacokinetics of DRF-4367, a new COX-2 inhibitor in rats.
Ramesh M; Mamidi RN; Jagannath K; Singh SK; Rao KS; Rao YK; Seshagirirao C; Rajagopalan R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2003; 28(2):137-41. PubMed ID: 12877572
[TBL] [Abstract][Full Text] [Related]
25. A pharmacokinetic study on a novel anti-HBV agent imidol hydrochloride in rats.
Liu Z; Peng Y; Ma B; Bi K; Liu Y; Sun G; Ping G; Guo Y
Int J Pharm; 2014 Jan; 461(1-2):514-8. PubMed ID: 24333907
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and tissue distribution of galantamine and galantamine-related radioactivity after single intravenous and oral administration in the rat.
van Beijsterveldt L; Geerts R; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
Arzneimittelforschung; 2004; 54(2):85-94. PubMed ID: 15038457
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
28. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
[TBL] [Abstract][Full Text] [Related]
29. Assessment of oral bioavailability and preclinical pharmacokinetics of DRF-6196, a novel oxazolidinone analogue, in comparison to linezolid.
Bhamidipati R; Venkatesh P; Dravid PV; Narasimhulu PC; Tvrs S; Das J; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2005; 30(3):187-93. PubMed ID: 16250256
[TBL] [Abstract][Full Text] [Related]
30. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in the pharmacokinetics of rivastigmine in rats.
Arumugam K; Chamallamudi MR; Mallayasamy SR; Ganesan S; Shavi GV; Averineni R; Reddy R; Bhat K; Udupa N
Arzneimittelforschung; 2009; 59(10):493-7. PubMed ID: 19998576
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of pioglitazone in lean and obese cats.
Clark MH; Hoenig M; Ferguson DC; Dirikolu L
J Vet Pharmacol Ther; 2012 Oct; 35(5):428-36. PubMed ID: 22612529
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats.
Michels GM; Boudinot FD; Ferguson DC; Hoenig M
Am J Vet Res; 2000 Jul; 61(7):775-8. PubMed ID: 10895899
[TBL] [Abstract][Full Text] [Related]
35. Bioequivalence evaluation of two rosiglitazone tablet formulations.
Yusuf A; Al-Gaai E; Hammami MM
Arzneimittelforschung; 2006; 56(11):740-3. PubMed ID: 17220051
[TBL] [Abstract][Full Text] [Related]
36. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
38. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
39. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
40. Validated HPLC method for determination of PAT-5A, an insulin sensitizing agent, in rat plasma.
Kumar VV; Katneni K; Chaluvadi MR; Shreeram S; Gangadhar S; Nataraj B; Kishore PH; Bhushan V; Subramaniam S
J Pharm Biomed Anal; 2000 Mar; 22(2):251-5. PubMed ID: 10719907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
